According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has ...
The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.
Bausch + Lomb said enVista Envy intraocular lenses will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. The company is in the process of seeking ...